Profil
Jaap Koopman is the founder of Profibrix BV, serving as Chief Scientific Officer since 2004.
Dr. Koopman is the founder of Fibriant BV, serving as Chief Executive Officer since 2015.
Former job includes Scientific Director & Project Manager at Pharming Group NV from 1998 to 2003.
Education includes a doctorate from the University of Leiden, conferred in 1992.
Postes actifs de Jaap Koopman
| Sociétés | Poste | Début |
|---|---|---|
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Fondateur | 01/01/2004 |
Fibriant BV
Fibriant BV Pharmaceuticals: OtherHealth Technology Provides research and development of of human fibrinogen | Directeur Général | 01/01/2015 |
Anciens postes connus de Jaap Koopman
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Formation de Jaap Koopman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Fibriant BV
Fibriant BV Pharmaceuticals: OtherHealth Technology Provides research and development of of human fibrinogen | Health Technology |
















